Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral docetaxel (ModraDoc005) absorption and excretion study with ritonavir
NL-OMON38495Withdrawn
- Sponsor
- Netherlands Cancer Institute
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ModraDoc 005 and ritonavir in cancer (2 arms), sponsored by Netherlands Cancer Institute. Planned start Sep 2013; status: withdrawn.
02
Drugs
ModraDoc 005ritonavir
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON38495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38495.